Paid Clinical Trials in Indianapolis, IN
Here are the 6 most popular medical studies in paid studies indianapolis
Hormone Therapy
Elinzanetant for Menopausal Sleep Disturbances
Recruiting0 awardsPhase 2
Indianapolis, Indiana
This trial will investigate a potential new treatment to help women with sleep disturbances associated with menopause. Researchers will analyze how the treatment affects sleep quality. Participants will take elinzanetant or placebo for 12 weeks and have 5 visits to the study site.
Offspring of non-smokers for Pulmonary Function Tests
Recruiting0 awards1 criteria
Indianapolis, Indiana
The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function at 10 years of age in their offspring. This is an additional continuation of the Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) trial, to follow the offspring through 10 years of age. The hypothesis for this protocol is an extension of the VCSIP trial that supplemental vitamin C in pregnant smokers can significantly improve their children's airway function tests. The investigators aim to demonstrate sustained improvement in airway/pulmonary function and trajectory through 10 years of age.
Popular filter options for paid studies indianapolis trials
Phase 3 Clinical Trials
View 93 phase 3 medical studies.
Monoclonal Antibodies
Odronextamab + Chemotherapy for Diffuse Large B-cell Lymphoma
Recruiting2 awardsPhase 3
Noblesville, Indiana
This trial is testing an experimental drug (odronextamab) with chemotherapy to treat diffuse large B-cell lymphoma (DLBCL) in patients previously untreated, relapsed, or refractory. It will compare the effectiveness to the current standard of care to see how safe and tolerable it is.
Monoclonal Antibodies
Odronextamab + Chemotherapy for Follicular Lymphoma
Recruiting2 awardsPhase 3
Noblesville, Indiana
This trial is looking into an experimental drug to treat follicular lymphoma (type of NHL). It will look at the drug's safety & effectiveness compared to current standard of care. It will also look at side effects & impact on quality of life.
Clinical Trials With No Placebo
View 93 medical studies that do not have a placebo group.
Participants with emergent large vessel occlusion undegoing intracranial mechanical thromebctomy for Stroke
Recruiting1 award1 criteria
Indianapolis, Indiana
The aim of this study is to develop a multicenter registry of patient data and outcomes for patients undergoing intracranial thrombectomy for acute ischemic stroke secondary to emergent large vessel occlusion with delivery of reperfusion catheter over a novel macrowire (Aristotle Colossus) to perform intracranial mechanical thrombectomy.
Monoclonal Antibodies
Odronextamab + Chemotherapy for Diffuse Large B-cell Lymphoma
Recruiting2 awardsPhase 3
Noblesville, Indiana
This trial is testing an experimental drug (odronextamab) with chemotherapy to treat diffuse large B-cell lymphoma (DLBCL) in patients previously untreated, relapsed, or refractory. It will compare the effectiveness to the current standard of care to see how safe and tolerable it is.
Monoclonal Antibodies
Odronextamab + Chemotherapy for Follicular Lymphoma
Recruiting2 awardsPhase 3
Noblesville, Indiana
This trial is looking into an experimental drug to treat follicular lymphoma (type of NHL). It will look at the drug's safety & effectiveness compared to current standard of care. It will also look at side effects & impact on quality of life.
Individuals with sickle cell trait for Sickle Cell Trait
Recruiting1 award4 criteria
Indianapolis, Indiana
The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.
View More Paid Studies Indianapolis Trials
See another 78 many medical studies focused on paid studies indianapolis.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.